Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Medical-detection Dogs to Identify People With SARS-CoV-2. Phase 2 and 3 -Training Dogs to Detect People Infected With SARS-CoV-2.

NCT04948190 is registered in ClinicalTrials.gov with ARCTEC as lead sponsor.

NCT NCT04948190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04948190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Medical-detection Dogs to Identify People With SARS-CoV-2. Phase 2 and 3 -Training Dogs to Detect People Infected With SARS-CoV-2.
Lead sponsor
ARCTEC
Phase
Observational
Overall status
Unknown status
Start date
March 8, 2021
Completion date
September 27, 2021
Enrollment
11,015 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, sars-cov2 infection